अApnaFunda

ENTERO HEALTHCARE SOL LIMITED (ENTERO)

Distribution Services · Medical Distributors · figures to Nov '26

Quality scoreHow the business itself ranks against its sector peers on profitability, 3-year growth and leverage. 50 is the middle of the sector.51 / 100
Profitability 48Balance sheet 54
Momentum scoreHow strong the recent trend is: 3-month price change, 12-month improvement in earnings and the rise in FII + DII holding, among companies above ₹500 cr.55 / 100
Price 99Earnings 65FII/DII 2

Passes these screensHigh MomentumNear 52-week high

Compare withMONO PHARMACARE

Share price

Closing priceAdjusted for splits and bonus issues.

₹2,114.9 latest close · +74.4% over the last 90 sessions

₹1,500₹2,000Jul 3Jul 29Aug 24Sep 17Oct 14Nov 9 ₹1,500₹2,000Jul 3Sep 4Nov 9

₹2,114.9 month-end · +99.0% over 12 months

₹1,000₹1,500₹2,000Nov '25Jan '26Apr '26Jun '26Sep '26Nov '26 ₹1,000₹1,500₹2,000Nov '25May '26Nov '26

₹2,114.9 month-end · +95.3% since Feb '24

₹1,000₹1,500₹2,000Feb '24Sep '24Mar '25Oct '25Apr '26Nov '26 ₹1,000₹1,500₹2,000Feb '24Jul '25Nov '26

52-week range ₹944.00 to ₹2137.60 · 1-year volatility 42.4%

Was the rally earned?

+99%share price, 1 yearMultiple-driven

Partly.

  • Most of the rise came from investors paying a higher multiple (P/E 45.1x to 73.4x); per-share earnings added 29 points.
  • The share count rose 18%.
Net profit growth: +53 pts. Points of the price return explained by net profit growing (or shrinking).+53 ptsNet profit growthP/E change: +70 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+70 ptsP/E changeShare count change: −24 pts. Points of the price return explained by the share count changing. More shares count against the price.−24 ptsShare count changeShare price: +99%+99%Share priceNet profit growth: +53 pts. Points of the price return explained by net profit growing (or shrinking).+53ProfitP/E change: +70 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+70P/EShare count change: −24 pts. Points of the price return explained by the share count changing. More shares count against the price.−24SharesShare price: +99%+99%Share price
Net profit growth+53 ptsNet profit rose about 45%, which lifts the price.
P/E change+70 ptsThe P/E rose from 45.1x to 73.4x, which lifts the price.
Share count change-24 ptsShare count rose 18%, which lowers the price.
What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Not shown for 3 years and 5 years: earnings were negative at one end, or there is not enough history.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with MONO PHARMACARE

How rough has the ride been?

Maximum drawdown-38.7%recovered 2026-08
1-year volatility42.4%annualised
Beta vs sector index0.203-year daily, correlation 0.17
Volume spikes11last 90 sessions, 5x the 50-day median

Drawdown from peak

0%−20%−40%20252026−38.5% 0%−20%−40%20252026−38.5%
Largest drawdowns

-38.7% (2025-02 peak to 2025-12 low, recovered 2026-08)

-22.7% (2026-09 peak to 2026-10 low, recovered 2026-11)

-17.6% (2024-04 peak to 2024-05 low, recovered 2024-08)

Most recent volume spikes

2026-11-09: 6.2x the 50-day median, price +4.4% that day

2026-11-06: 9.2x the 50-day median, price +8.3% that day

2026-11-05: 11.8x the 50-day median, price +5.4% that day

Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).

Is it expensive against its own past and its peers?

73.4xP/E todayNear its historic high
Against its own history87th percentile
CheapestMedian 53.4xDearest

Usual range 43.2x to 75.2x since 2024-02.

Against Distribution Services73.4x vs 16.7x
This company
73.4x
Sector median
16.7x

338% above the Distribution Services median.

16.4x38.2x60.0x81.8xFeb '24Sep '24Apr '25Nov '25Jun '26Nov '2616.4x38.2x60.0x81.8xFeb '24Jan '25Dec '25Nov '26
P/E (this company)10th to 90th percentile of its own historyIts medianDistribution Services median

The chart loads when you open this tab.

P/B (this company)10th to 90th percentile of its own historyIts medianDistribution Services median

The chart loads when you open this tab.

P/S (this company)10th to 90th percentile of its own historyIts medianDistribution Services median
How to read this

Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).

Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.

All terms explained in the glossary →

How Distribution Services is valued

Where does it rank among Distribution Services peers?

Each cell is the company's percentile rank among its Distribution Services peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

Where it ranks today

  • ROCE52nd▲ 6 pts vs a year ago
  • Op. margin44th▼ 5 pts vs a year ago
  • Revenue growth83rd▲ 3 pts vs a year ago
  • EPS growth59th▼ 5 pts vs a year ago
  • Debt/equity ↓45th▼ 10 pts vs a year ago
  • Cash cycle ↓57th▲ 11 pts vs a year ago
  • P/E ↓16th▼ 15 pts vs a year ago
  • 12M momentum94th▲ 38 pts vs a year ago

Rank history

ROCE
Op. margin
Revenue growth
EPS growth
Debt/equity ↓
Cash cycle ↓
P/E ↓
12M momentum
Dec '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '26Nov '26
Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Distribution Services sector page Watch it move against Distribution Services in the Observatory

What is the price implying?

~31%annual earnings growth implied by the price

At a P/E of 73.4x, the price would imply about 31.3%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.

Fewer than six years of annual earnings are available, which is too little to measure delivered growth.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect.

What prices imply across Distribution Services The market-wide Expectations lists

Key figures

Share Priceclose 9 Nov
₹2114.90
P/E
73.4x
ROCE
10.0%
Market Cap
₹9216 cr
Revenue (TTM)
₹7128 cr
P/S
1.3x
P/B
5.5x
ROE
7.4%
Operating Margin
5.0%
Debt / Equity
0.4x
Promoter Holding
52.4%
12M Momentum
99.0%

52-week range

₹944.00₹2137.60
98% of the way from its 52-week low to its high

Price risk

1Y volatility
42.4%
Beta vs sector
1-year daily
0.15

Balance sheet & cash

Interest cover
operating profit ÷ interest
4.3x
Cash from profit, 3Y
operating cash flow ÷ net profit
-0.06x
low
Share count, 1Y
unchanged

Are profits backed by cash?

5 of 7checks within range2 beyond a threshold
Other income reliance4%Within range

Other income as a share of pre-tax profit (trailing twelve months): 3.8%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate20%Within range

Median quarterly effective tax rate over about 2.5 years: 20.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion-0.06xBeyond threshold

Operating cash flow divided by net profit over the last three fiscal years: -0.06x (cash from operations ₹-18 cr, net profit ₹293 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow1 of 5 yrsBeyond threshold

Fiscal years with positive free cash flow in the last 5: 1. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history+9 daysWithin range

Debtor days are above the median of the previous three fiscal years by 9 days (67 vs 58). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress0% of fixed assetsWithin range

Capital work-in-progress is 0% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days+21 days / 2 yrsWithin range

Days payable changed by +21 over two years. Bands: rise of up to 30 days; more than 30 days.

Tap a check to see how it is measured

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

  • Over 2 years, FIIs trimmed 18.9 pts; DIIs added 13.2 pts.
  • The number of shareholders fell from 80,864 to 39,709 (-51%) between Mar 2024 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupMar '24Jun '26Change
Promoters52.4%52.4%0.0 pts
FIIs23.3%4.4%-18.9 pts
DIIs2.3%15.5%+13.2 pts
Public and others22.0%27.8%+5.8 pts

Number of shareholders

39,709shareholders-51% since Mar '24
33k49k65k81k Mar '24Sep '24Mar '25Sep '25Mar '26Jun '26
Mar '24: 80,864
Jun '24: 66,400
Sep '24: 36,767
Dec '24: 33,172
Mar '25: 33,159
Jun '25: 33,338
Sep '25: 36,334
Dec '25: 40,333
Mar '26: 39,084
Jun '26: 39,709
33k49k65k81k Mar '24Dec '24Sep '25Jun '26
Mar '24: 80,864
Jun '24: 66,400
Sep '24: 36,767
Dec '24: 33,172
Mar '25: 33,159
Jun '25: 33,338
Sep '25: 36,334
Dec '25: 40,333
Mar '26: 39,084
Jun '26: 39,709

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

What happened next to similar setups

−3.0%typical 12-month return vs the marketNot meaningfully different from the base rate
  • We found 50 past situations where a non-financial company looked like ENTERO HEALTHCARE SOL LIMITED today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
  • Over the following 12 months the middle half of them returned −25% to +43% vs the market, against −2% for all non-financial companies in the same months.
  • The gap against the base rate (−0.8%, 80% range −9.5% to +9.2%) is within what chance and overlapping periods produce.

Where the 50 outcomes landed

−100%−50%0%+50%+100%
HITECH · Aug 2024: −51.9% vs market
STAR · Sep 2020: −49.9% vs market
SIS · Mar 2020: −49.6% vs market
KEC · Dec 2024: −41.7% vs market
PARAGMILK · Sep 2023: −38.0% vs market
SUDARSCHEM · Jul 2025: −33.0% vs market
TEXRAIL · Jun 2024: −30.6% vs market
EMIL · Oct 2023: −27.8% vs market
SOMANYCERA · Sep 2021: −27.8% vs market
BEML · Nov 2021: −27.3% vs market
SHK · May 2021: −25.9% vs market
BIL · Jul 2025: −25.8% vs market
SOBHA · Apr 2024: −24.8% vs market
BIRLACORPN · Jan 2020: −24.3% vs market
ORIENTBELL · Feb 2022: −18.1% vs market
KDDL · Oct 2023: −17.7% vs market
GANECOS · Dec 2022: −16.5% vs market
LUMAXIND · Apr 2023: −15.8% vs market
BIRLANU · Apr 2021: −14.0% vs market
PGEL · Feb 2023: −12.7% vs market
MEDPLUS · May 2025: −9.4% vs market
RKFORGE · Sep 2021: −8.6% vs market
GREENPANEL · Oct 2021: −7.0% vs market
AMBER · Mar 2025: −6.7% vs market
GREENPLY · Jul 2024: −3.7% vs market
CAMLINFINE · Sep 2020: −2.3% vs market
NH · Jan 2020: −0.9% vs market
FORCEMOT · Feb 2024: +3.0% vs market
JBMA · Nov 2021: +4.7% vs market
KALYANKJIL · Jun 2024: +8.6% vs market
RAMRAT · Jul 2025: +9.5% vs market
VADILALIND · Jun 2022: +16.3% vs market
PASHUPATI · Jul 2025: +17.5% vs market
STYRENIX · Jun 2020: +18.5% vs market
NACLIND · Jun 2020: +19.5% vs market
ARTEMISMED · Sep 2023: +23.5% vs market
POWERMECH · Mar 2023: +36.5% vs market
GALLANTT · Apr 2024: +45.2% vs market
KIRLOSENG · Mar 2023: +46.0% vs market
HSCL · Dec 2023: +60.7% vs market
ESTER · Jun 2020: +61.0% vs market
NEULANDLAB · Jul 2020: +62.5% vs market
CEMPRO · May 2023: +71.2% vs market
AARTIDRUGS · May 2020: +71.8% vs market
SYRMA · Aug 2025: +77.1% vs market
APLAPOLLO · Feb 2020: +102.7% vs market
EKC · Nov 2020: +110.7% vs market
THANGAMAYL · Aug 2025: +122.8% vs market
AVALON · Sep 2025: +126.3% vs market
ADANIENT · Oct 2020: +162.5% vs market
Similar setups −3.0%All companies −2.2%← worse than the marketbetter than the market →

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 5 beyond the range shown, drawn at the edge

Similar setups' median
−3.0%
All companies' median
−2.2%
Beat the market
46% vs 48%

50 past situations · 50 companies · 35 months · 2020–2025

The closest matches

CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
NEULANDLAB
Health Technology
Jul 2020 62x8% +58%0% +63%
GREENPANEL
Non-Energy Minerals
Oct 2021 69x12% +426%0% −7%
NACLIND
Process Industries
Jun 2020 47x10% +29%−1% +20%
AMBER
Producer Manufacturing
Mar 2025 110x10% +97%−11% −7%
SUDARSCHEM
Process Industries
Jul 2025 177x6% +53%0% −33%
Show the other 3 matches
CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
BIRLACORPN
Non-Energy Minerals
Jan 2020 24x8% +64%0% −24%
KALYANKJIL
Retail Trade
Jun 2024 86x14% +241%0% +9%
JBMA
Producer Manufacturing
Nov 2021 90x9% +246%−1% +5%
How reliable is this?

Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: interest cover, ROCE and revenue growth. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 5 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to ENTERO HEALTHCARE SOL LIMITED. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-11-09. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

FeatureWeightNon-financialFinancial
P/E1yesyes
P/S1yes—
P/B1—yes
ROCE1yes—
operating margin1yes—
ROE1—yes
debt/equity0.75yes—
interest cover0.5yes—
revenue growth0.75yesyes
12-month momentum1yesyes
drawdown from 12-month high0.75yesyes
size0.75yesyes
volatility0.5yesyes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

  • One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
  • Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
  • Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
  • Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
  • Pools: non-financial: 98,395 company-months from 2019 companies; financial: 5,659 company-months from 108 companies. 2349 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

SG MARTSGMART
Utilities
73%similar
ROCErevenue
GREAVES COTTONGREAVESCOT
Producer Manufacturing
71%similar
ROCEoperating margin
Transportation
71%similar
revenueoperating margin
Electronic Technology
71%similar
ROCEP/E
PDSPDSL
Consumer Non-Durables
67%similar
volatilityoperating margin
Distribution Services
28%similar
market capP/E
Distribution Services
28%similar
operating marginROCE
Distribution Services
11%similar
operating margindebt/equity

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What changed?

24 events since Apr '24

  1. NovPriceVolume reached 11.8x its 50-day median on 2026-11-05; price +5.4% that day.
  2. AugPriceRegained the 2025-02 peak, 8 months after the low.
  3. AugPriceVolume reached 28.0x its 50-day median on 2026-08-25; price +6.7% that day.
  4. JunInstitutionsFII + DII holding fell 3.7 pts over 2 quarters to 20.7%.
  5. JunPeer rankMoved into the 2nd quartile of Distribution Services on ROCE (from the 3rd quartile).
  6. MayPriceVolume reached 7.5x its 50-day median on 2026-05-26; price -4.9% that day.
  7. JanPriceVolume reached 18.2x its 50-day median on 2026-01-06; price +7.2% that day.
  8. DecPriceFell 39% from the Feb 2025 peak to the Dec 2025 low.
Show 16 earlier events
  1. DecPeer rankMoved into the 2nd quartile of Distribution Services on operating margin (from the 3rd quartile).
  2. DecPriceVolume reached 9.7x its 50-day median on 2025-12-30; price +6.0% that day.
  3. SepResultsYear-on-year EPS growth turned positive.
  4. SepInstitutionsFII + DII holding fell 3.6 pts over 2 quarters to 27.4%.
  5. SepPeer rankSlipped to the 3rd quartile of Distribution Services on operating margin (from the 2nd quartile).
  6. SepPriceVolume reached 6.0x its 50-day median on 2025-09-30; price +3.8% that day.
  7. MayPriceVolume reached 6.0x its 50-day median on 2025-05-28; price -8.2% that day.
  8. MarPeer rankMoved into the 2nd quartile of Distribution Services on operating margin (from the 3rd quartile).
  9. FebSharesShare count is up 200.0% over 12 months.
  10. FebPriceVolume reached 8.7x its 50-day median on 2025-02-05; price +1.6% that day.
  11. DecInstitutionsFII + DII holding rose 6.2 pts over 1 quarter to 31.6%.
  12. NovPriceVolume reached 8.3x its 50-day median on 2024-11-25; price +1.4% that day.
  13. OctPeer rankSlipped to the 3rd quartile of Distribution Services on operating margin (from the 2nd quartile).
  14. SepPriceVolume reached 5.6x its 50-day median on 2024-09-05; price +1.2% that day.
  15. JunResultsEPS (TTM) turned positive.
  16. AprPriceVolume reached 7.6x its 50-day median on 2024-04-12; price +16.8% that day.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Monthly history34 months · 2024-02 to 2026-11
MonthP/ERevenue (TTM)ROEROCEDebt / Equity
2026-1173.4x₹7128 cr7.4%10.0%0.4x
2026-1054.7x₹7128 cr7.4%10.0%0.4x
2026-0959.3x₹7128 cr7.4%10.0%0.4x
2026-0868.5x₹6592 cr6.5%10.0%0.4x
2026-0747.0x₹6592 cr6.5%10.0%0.4x
2026-0645.0x₹6592 cr6.5%10.0%0.4x
2026-0546.2x₹6021 cr5.7%9.0%0.2x
2026-0447.0x₹6021 cr5.7%9.0%0.2x
2026-0348.2x₹6021 cr5.7%9.0%0.2x
2026-0240.6x₹5673 cr5.5%9.0%0.2x
2026-0143.5x₹5673 cr5.5%9.0%0.2x
2025-1240.4x₹5673 cr5.5%9.0%0.2x
2025-1145.1x₹5403 cr5.0%9.0%0.2x
2025-1046.9x₹5403 cr5.0%9.0%0.2x
2025-0947.3x₹5403 cr5.0%9.0%0.2x
2025-0854.2x₹5096 cr4.6%9.0%0.2x
2025-0759.0x₹5096 cr4.6%9.0%0.2x
2025-0652.6x₹5096 cr4.6%9.0%0.2x
2025-0557.9x₹4791 cr4.4%7.0%0.2x
2025-0463.4x₹4791 cr4.4%7.0%0.2x
2025-0354.9x₹4791 cr4.4%7.0%0.2x
2025-0266.3x₹4425 cr3.4%7.0%0.2x
2025-0170.7x₹4425 cr3.4%7.0%0.2x
2024-1274.6x₹4425 cr3.4%7.0%0.2x
2024-1180.3x₹4120 cr2.5%7.0%0.2x
2024-1081.8x₹4120 cr2.5%7.0%0.2x
2024-0981.1x₹4120 cr2.5%7.0%0.2x
2024-0849.9x₹3922 cr1.8%7.0%0.2x
2024-0743.6x₹3922 cr1.8%7.0%0.2x
2024-0637.9x₹3922 cr1.8%7.0%0.2x
2024-05—₹3300 cr—5.0%—
2024-04—₹3300 cr—5.0%—
2024-03—₹3300 cr—5.0%—
2024-02—₹3300 cr—5.0%—

Methodology and data notes

Methodology

Methodology and data notes

All figures come from public exchange prices and screener.in financial statements. Quarterly and annual results are shown from 60 days after the period end, so a month never uses a result before it would plausibly have been published. Statements are the latest versions, which may include later restatements.

Sector medians, percentiles and indices use today's listed companies in the sector (survivorship bias). Prices are adjusted for splits and bonus issues; around a corporate action the fundamentals may lag the price by up to a month, and affected sections are hidden.

The return decomposition uses price = P/E × net profit ÷ share count. The reverse DCF uses a fixed 12% cost of equity, a 10-year horizon and a 15x terminal P/E, and is an illustration only. Events, flags and twins follow fixed rules and thresholds described next to each section.

Feedback